CoChat

The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing Hormone

Open access

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Suppression of pituitary-adrenal function is a well-known consequence of glucocorticoid therapy, manifested principally by decreased corticotropin secretion. To determine the degree of suppression of pituitary-adrenal function in patients treated with different doses of synthetic glucocorticoid medication for different periods, we measured the pituitary-adrenal response to the administration of exogenous human corticotropin-releasing hormone (CRH). METHODS: We studied 279 patients who were receiving daily therapy with 5 to 30 mg of prednisone or its equivalent to treat various chronic diseases, principally collagen vascular disorders, and 50 normal subjects. Therapy ranged in duration from 1 week to 15 years. Stimulation tests using 100 micrograms of CRH as a bolus injection were performed in the morning, 24 hours after the most recent dose of glucocorticoids. In 61 patients an insulin hypoglycemia test, thought by many to be the reference standard, was also performed to assess the reliability of the CRH results. RESULTS: After the administration of CRH, 43 patients had no increase in plasma concentrations of corticotropin and cortisol. The response was blunted in 133 patients and normal in 103. There was poor correlation between the plasma cortisol response after the administration of CRH and the dose or duration of therapy or the basal plasma cortisol concentration. Although plasma cortisol concentrations after stimulation with CRH were generally lower than those after insulin administration, there was a significant correlation between the plasma cortisol responses to the two stimuli (r = 0.82). CONCLUSIONS: Pituitary-adrenal function in patients treated with synthetic glucocorticoids cannot be reliably estimated from the dose of glucocorticoid, the duration of therapy, or the basal plasma cortisol concentration. In such patients, testing with CRH is nearly as useful as insulin hypoglycemia testing in the assessment of pituitary-adrenal function.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199201233260403

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 3

  1. Bolt, 1980, Therapiewoche, 30, 6257
  2. Voigt, 1981, Therapiewoche, 31, 6230
  3. Becker KL. Endocrine drugs and values. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. Philadelphia: J.B. Lippincott, 1990:1740.

Cited by

See all 381

Metadata

Authors
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P.
Affiliations
Heinrich Heine University Düsseldorf (DE)
Venue
New England Journal of Medicine
Published
1992-01-23
Volume
326
Issue
4
Pages
226-230
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1976008242
Cited by
381
References
28
Citations by year
2026: 4 · 2025: 6 · 2024: 12 · 2023: 5 · 2022: 8 · 2021: 10 · 2020: 11 · 2019: 7 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 12 · 2014: 11 · 2013: 17 · 2012: 10
FWCI
9.83
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
glucocorticoid therapy, pituitary-adrenal axis, corticotropin-releasing hormone stimulation test, prednisone, insulin hypoglycemia test, plasma cortisol, connective tissue diseases, long-term corticosteroid therapy
MeSH terms
Adrenocorticotropic Hormone, Adult, Aged, Aged, 80 and over, Blood Glucose, Corticotropin-Releasing Hormone, Depression, Chemical, Female, Glucocorticoids, Humans, Hydrocortisone, Insulin, Male, Middle Aged, Pituitary-Adrenal Function Tests, Pituitary-Adrenal System, Prednisone, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.